{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:43:47Z","timestamp":1790189027212,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116849","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:53:43Z","timestamp":1725627223000},"page":"116849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Replacement of the essential nitro group by electrophilic warheads towards nitro-free antimycobacterial benzothiazinones"],"prefix":"10.1016","volume":"279","author":[{"given":"H\u00e9ctor","family":"Torres-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Keiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hortschansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Kerndl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Messerschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dal Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rybniker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel A.","family":"Brakhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2283-1457","authenticated-orcid":false,"given":"Florian","family":"Kloss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116849_bib1","series-title":"Global Tuberculosis Report 2022","year":"2022"},{"key":"10.1016\/j.ejmech.2024.116849_bib2","series-title":"WHO Consolidated Guidelines on Tuberculosis Module 4: Treatment Drug-Susceptible Tuberculosis Treatment","year":"2022"},{"key":"10.1016\/j.ejmech.2024.116849_bib3","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","article-title":"Tuberculosis","volume":"393","author":"Furin","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116849_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116849_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jgar.2022.09.001","article-title":"Pretomanid development and its clinical roles in treating tuberculosis","volume":"31","author":"Fekadu","year":"2022","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.ejmech.2024.116849_bib7","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1021\/acs.jmedchem.8b01153","article-title":"Emerging and Re-emerging warheads for targeted covalent inhibitors: applications in medicinal chemistry and chemical biology","volume":"62","author":"Gehringer","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib8","series-title":"Tolerability and Early Bactericidal Activity (EBA)","article-title":"BTZ-043 - multiple ascending dose (MAD) to evaluate safety","author":"Hoelscher","year":"2019"},{"key":"10.1016\/j.ejmech.2024.116849_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116849_bib10","doi-asserted-by":"crossref","first-page":"13663","DOI":"10.1021\/ja106357w","article-title":"Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl- \u03b2-D-ribose 2\u2032-epimerase DprE1 of mycobacterium tuberculosis","volume":"132","author":"Trefzer","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116849_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004395","article-title":"Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis","volume":"4","author":"Neres","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2024.116849_bib12","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/anie.201609737","article-title":"In vivo dearomatization of the potent antituberculosis agent BTZ043 via meisenheimer complex formation","volume":"56","author":"Kloss","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.116849_bib13","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1021\/jm3008882","article-title":"Identification of antitubercular benzothiazinone compounds by ligand-based design","volume":"55","author":"Karoli","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib14","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/C6RA25712G","article-title":"Design, synthesis and antitubercular evaluation of benzothiazinones containing an oximido or amino nitrogen heterocycle moiety","volume":"7","author":"Zhang","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116849_bib15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1021\/acsmedchemlett.7b00106","article-title":"Identification of better pharmacokinetic benzothiazinone derivatives as new antitubercular agents","volume":"8","author":"Lv","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116849_bib16","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1039\/C8RA00720A","article-title":"Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles","volume":"8","author":"Xiong","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116849_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200021","article-title":"New Insight into Dearomatization and Decarbonylation of Antitubercular 4 H \u2010Benzo[ e ][1,3]thiazinones: Stable 5 H \u2010 and 7 H \u2010Benzo[ e ][1,3]thiazines","volume":"17","author":"Richter","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116849_bib18","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1021\/acs.jmedchem.2c00098","article-title":"Development of predictive classification models for whole cell antimycobacterial activity of benzothiazinones","volume":"65","author":"Schieferdecker","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib19","volume":"vol. 2020406","author":"Makarov","year":"2009"},{"key":"10.1016\/j.ejmech.2024.116849_bib20","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.bmcl.2013.06.069","article-title":"Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents","volume":"23","author":"Gao","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116849_bib21","doi-asserted-by":"crossref","first-page":"14526","DOI":"10.1021\/acs.jmedchem.1c01049","article-title":"Structural and activity relationships of 6-sulfonyl-8-nitrobenzothiazinones as antitubercular agents","volume":"64","author":"Fan","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300099","article-title":"DprE1 inhibitors: enduring aspirations for future antituberculosis drug discovery","volume":"18","author":"Yadav","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116849_bib23","doi-asserted-by":"crossref","DOI":"10.1039\/D3CC00356F","article-title":"Synthesis, structures, reactivity and medicinal chemistry of antitubercular benzothiazinones","author":"Seidel","year":"2023","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.116849_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s42004-024-01235-x","article-title":"Modulation of the Meisenheimer complex metabolism of nitro-benzothiazinones by targeted C-6 substitution","volume":"7","author":"Keiff","year":"2024","journal-title":"Commun. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib25","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1128\/AAC.00778-15","article-title":"The 8-pyrrole-benzothiazinones are noncovalent inhibitors of DprE1 from Mycobacterium tuberculosis, antimicrob","volume":"59","author":"Makarov","year":"2015","journal-title":"Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116849_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/acsmedchemlett.5b00424","article-title":"Design, syntheses, and anti-TB activity of 1,3-benzothiazinone azide and click chemistry products inspired by BTZ043","volume":"7","author":"Tiwari","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116849_bib27","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00044-021-02735-4","article-title":"Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones","volume":"30","author":"Madikizela","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.116849_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-31316-6","article-title":"Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1","volume":"8","author":"Richter","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116849_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2020.112773","article-title":"Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents","volume":"208","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib30","doi-asserted-by":"crossref","first-page":"13775","DOI":"10.1002\/slct.202004156","article-title":"Molecular insight into the discrepancy of antitubercular activity between 8-nitro and 8-cyano benzothiazinones","volume":"5","author":"Zhang","year":"2020","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2024.116849_bib31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00044-020-02676-4","article-title":"8-Cyanobenzothiazinone analogs with potent antitubercular activity","volume":"30","author":"Zhang","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.116849_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116023","article-title":"Whole cell hydride Meisenheimer complex biotransformation guided optimization of antimycobacterial benzothiazinones","volume":"264","author":"Joch","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib33","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.bmc.2019.04.002","article-title":"Characterising covalent warhead reactivity","volume":"27","author":"Martin","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib34","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1002\/anie.201601091","article-title":"Targeted covalent inhibitors for drug design","volume":"55","author":"Baillie","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.116849_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115357","article-title":"Comparative reactivity analysis of small-molecule thiol surrogates","volume":"28","author":"Petri","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib36","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1002\/anie.201814715","article-title":"Cysteine-selective phosphonamidate electrophiles for modular protein bioconjugations","volume":"58","author":"Kasper","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.116849_bib37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1039\/c4tx00059e","article-title":"In vitro studies on the reaction rates of acrylamide with the key body-fluid thiols l -cysteine, glutathione, and captopril","volume":"3","author":"Bent","year":"2014","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.ejmech.2024.116849_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejmech.2018.10.010","article-title":"A road map for prioritizing warheads for cysteine targeting covalent inhibitors","volume":"160","author":"\u00c1br\u00e1nyi-Balogh","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1021\/acsinfecdis.5b00065","article-title":"Whole cell target engagement identifies novel inhibitors of Mycobacterium tuberculosis decaprenylphosphoryl-\u03b2- d -ribose oxidase","volume":"1","author":"Batt","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116849_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/anie.198001331","article-title":"New peptide synthesis, angew","volume":"19","author":"Wissmann","year":"1980","journal-title":"Chemie Int. Ed. English"},{"key":"10.1016\/j.ejmech.2024.116849_bib41","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1039\/C9SC01345H","article-title":"Vinylphosphonites for Staudinger-induced chemoselective peptide cyclization and functionalization","volume":"10","author":"Kasper","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2024.116849_bib42","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41429-020-0320-7","article-title":"Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis","volume":"73","author":"Lelovic","year":"2020","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2024.116849_bib43","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1021\/acs.jmedchem.2c00972","article-title":"Nitroimidazopyrazinones with oral activity against tuberculosis and chagas disease in mouse models of infection","volume":"65","author":"Ang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300356","article-title":"Design and synthesis of benzofuran\u2010 and naphthalene\u2010fused thiazinones as antimycobacterial agents","volume":"356","author":"Keiff","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.116849_bib45","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1021\/acs.jmedchem.9b02052","article-title":"Identification of the clinical development candidate MRTX849, a covalent KRASG12CInhibitor for the treatment of cancer","volume":"63","author":"Fell","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib46","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/chem.200802172","article-title":"Synthesis of a phosphonate-linked aminoglycoside-coenzyme a bisubstrate and use in mechanistic studies of an enzyme involved in aminoglycoside resistance","volume":"15","author":"Gao","year":"2009","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2024.116849_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"SLAS Discov"},{"key":"10.1016\/j.ejmech.2024.116849_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/mic.0.001288","article-title":"Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis","volume":"169","author":"Batt","year":"2023","journal-title":"Microbiology"},{"key":"10.1016\/j.ejmech.2024.116849_bib49","series-title":"Evaluation of Enzyme Inhibitors in Drug Discovery","author":"Copeland","year":"2013"},{"key":"10.1016\/j.ejmech.2024.116849_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.419","article-title":"A comprehensive guide for assessing covalent inhibition in enzymatic assays illustrated with kinetic simulations","volume":"2","author":"Mons","year":"2022","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.ejmech.2024.116849_bib51","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis, antimicrob","volume":"46","author":"Palomino","year":"2002","journal-title":"Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116849_bib52","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1038\/ncomms8659","article-title":"Lansoprazole is an antituberculous prodrug targeting cytochrome bc1","volume":"6","author":"Rybniker","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116849_bib53","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chembiol.2023.12.007","article-title":"Discovery of dual-active ethionamide boosters inhibiting the Mycobacterium tuberculosis ESX-1 secretion system","volume":"31","author":"Gries","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116849_bib54","series-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"key":"10.1016\/j.ejmech.2024.116849_bib55","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v012.i05","article-title":"Bioassay analysis using R","volume":"12","author":"Ritz","year":"2005","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.ejmech.2024.116849_bib56","doi-asserted-by":"crossref","first-page":"11354","DOI":"10.1073\/pnas.1205735109","article-title":"Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors","volume":"109","author":"Batt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.116849_bib57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsb.2011.02.001","article-title":"Deciphering correct strategies for multiprotein complex assembly by co-expression: application to complexes as large as the histone octamer","volume":"175","author":"Diebold","year":"2011","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ejmech.2024.116849_bib58","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib59","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116849_bib60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK a prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2024.116849_bib61","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342400730X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342400730X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T20:39:54Z","timestamp":1731271194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342400730X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":60,"alternative-id":["S022352342400730X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116849","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replacement of the essential nitro group by electrophilic warheads towards nitro-free antimycobacterial benzothiazinones","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116849"}}